Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Extension Study Evaluating the Safety of Zagociguat in Participants With MELAS Who Completed TIS6463-203

NCT06961344 is registered in ClinicalTrials.gov with Tisento Therapeutics as lead sponsor.

NCT NCT06961344
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06961344 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Extension Study Evaluating the Safety of Zagociguat in Participants With MELAS Who Completed TIS6463-203
Lead sponsor
Tisento Therapeutics
Phase
Phase 2
Overall status
Active, not recruiting
Start date
August 18, 2025
Completion date
July 31, 2028
Enrollment
44 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (melas syndrome)